Teva profit rises; Ratiopharm unit lifts sales

Teva Pharmaceutical’s third-quarter net income rises 62%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.